|
|
E R Seaquist, S E Kahn, P M Clark, C N Hales, D Porte, R P Robertson
J Clin Invest. 1996;
97(2):455
doi:10.1172/JCI118435
Abstract |
Full text
| PDF

T
he cause of disproportionate hyperproinsulinemia in patients with type II diabetes is controversial. To examine whether increased beta cell demand might contribute, we measured proinsulin and insulin concentrations in clinically healthy humans who had undergone hemipancreatectomy for the purpose of organ donation, a procedure previously demonstrated to increase beta cell demand and diminish insulin secretory reserve capacity. Subjects were studied at least 1 yr after hemipancreatectomy. Seven donors were followed prospectively and serves as their own controls. Nine additional donors were matched with normal controls (cross-sectional group). Fasting serum concentrations of intact proinsulin and conversion intermediates (total) were measured by a two-step radioimmunoassay; independent determinations of intact proinsulin and 32,33 split proinsulin were performed using an immunoradiometric assay. Serum total proinsulin values were significantly greater in hemipancreatectomized groups than controls (prospective group: predonation = 6.24 +/- 1.14 pM, postdonation = 34.63 +/- 17.47 pM, P < 0.005; cross-sectional group: controls = 5.78 +/- 1.12 pM, donors = 15.22 +/- 5.20 pM, P < 0.025). The ratio of total proinsulin to immunoreactive insulin was directly correlated with fasting plasma glucose and showed a significant inverse relationship to secretory reserve capacity. Both absolute and relative hyperproinsulinemia is found in hemipancreatectomized donors. These data demonstrate that partial pancreatectomy with its associated increase in beta cell demand raises measures of proinsulin in humans.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(25)
| Title and authors |
Publication |
Year |
Comprehensive Physiology
Gerald J. Taborsky
|
Comprehensive Physiology
|
2011 |
Review of approved pioglitazone combinations for type 2 diabetes
Thomas Forst, Markolf Hanefeld, Andreas Pfützner
|
Expert Opin. Pharmacother.
|
2011 |
Dual and opposing roles of the unfolded protein response regulated by IRE1 and XBP1 in proinsulin processing and insulin secretion
A.-H. Lee, K. Heidtman, G. S. Hotamisligil, L. H. Glimcher
|
Proceedings of the National Academy of Sciences
|
2011 |
Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults
A. Schölin, L. Nyström, H. Arnqvist, J. Bolinder, E. Björk, C. Berne, F. A. Karlsson
|
Diabetic Medicine
|
2011 |
Development of diabetes mellitus in living pancreas donors and recipients
Rainer WG Gruessner, Alberto Pugliese, Helena K Reijonen, Stephan Gruessner, Tun Jie, Chirag Desai, David ER Sutherland, George W Burke III
|
Expert Rev Clin Immunol
|
2011 |
Islet Transplantation: Factors in Short-Term Islet Survival
Natasha A. Deters, Rebecca A. Stokes, Jenny E. Gunton
|
Arch. Immunol. Ther. Exp.
|
2011 |
Short- and long-term outcome for living pancreas donors
Jason F. Reynoso, Christine E. Gruessner, David E. R. Sutherland, Rainer W. G. Gruessner
|
J Hepatobiliary Pancreat Sci
|
2009 |
Reduced postprandial proinsulinaemia and 32–33 split proinsulinaemia after a mixed meal in type 2 diabetic patients following sensitization to insulin with pioglitazone
Michael B. Cooper, Khulood Al Majali, Clifford J. Bailey, D. John Betteridge
|
Clinical Endocrinology
|
2008 |
Pancreas and Kidney Transplantation for Diabetic Nephropathy
Takashi Kobayashi, David E.R. Sutherland, Angelika C. Gruessner, Rainer W.G. Gruessner
|
Kidney Transplantation
|
2008 |
Middle Segment Pancreatectomy: A Useful Tool in the Management of Pancreatic Neoplasms
Claudio Bassi
|
J Gastrointest Surg
|
2007 |
|